share_log

AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144

AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144

艾伯維公司 | 144:擬議出售證券
美股SEC公告 ·  08/08 04:27
牛牛AI助理已提取核心訊息
Abbvie Inc. officer Hudson Thomas J is set to sell 101,886 shares of the company's common stock, with an aggregate market value of approximately $19,115,379.79. The sale is scheduled for 08/07/2024, which coincides with the date Hudson acquired the shares through a stock option exercise as part of his compensation from the issuer. This transaction follows a period where no securities transactions were reported by Hudson in the past three months.
Abbvie Inc. officer Hudson Thomas J is set to sell 101,886 shares of the company's common stock, with an aggregate market value of approximately $19,115,379.79. The sale is scheduled for 08/07/2024, which coincides with the date Hudson acquired the shares through a stock option exercise as part of his compensation from the issuer. This transaction follows a period where no securities transactions were reported by Hudson in the past three months.
Abbvie Inc.的高管Hudson Thomas J打算賣出公司的101,886股普通股,市值約爲19,115,379.79美元。該交易計劃於2024年08月07日進行,與Hudson作爲薪酬的一部分通過股票期權行使獲得股票的日期相重合。在過去的三個月裏,Hudson沒有報告任何證券交易。
Abbvie Inc.的高管Hudson Thomas J打算賣出公司的101,886股普通股,市值約爲19,115,379.79美元。該交易計劃於2024年08月07日進行,與Hudson作爲薪酬的一部分通過股票期權行使獲得股票的日期相重合。在過去的三個月裏,Hudson沒有報告任何證券交易。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。